Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Nephrolithiasis
ADR ID BADD_A03021
ADR Hierarchy
20      Renal and urinary disorders
20.04      Urolithiases
20.04.01      Renal lithiasis
20.04.01.002      Nephrolithiasis
Description Formation of stones in the KIDNEY. [MeSH]
MedDRA Code 10029148
MeSH ID D053040; D007669
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Calculus kidney | Calculus of kidney | Calculus of kidney and ureter | Calculus renal | Calculus renal NOS | Crystallization kidney | Kidney calculus | Kidney crystallisation | Kidney stone | Kidney stones | Nephrolithiasis | Renal calculi | Renal calculus | Renal calculus NOS | Renal stone | Uric acid nephrolithiasis | Unilateral renal calculus | Kidney crystallization | Crystallisation kidney | Renal pelvic calcification | Nephrolithiasis recurrent | Gouty diathesis | Ureteropelvic junction stone | Renal microlithiasis | Bilateral nephrolithiasis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02470Nintedanib0.000280%
BADD_D02473Sodium chloride--
BADD_D02487Baricitinib0.001230%
BADD_D02490Apalutamide0.000901%
BADD_D02492Deflazacort0.000418%
BADD_D02498Abemaciclib0.000302%
BADD_D02510Rucaparib0.000280%
BADD_D02511Siponimod0.000362%
BADD_D02515Pexidartinib0.000112%
BADD_D02539Calcium0.000979%
BADD_D02548Darolutamide0.000334%
BADD_D02549Deucravacitinib0.000241%
BADD_D02580Ozanimod0.001326%
BADD_D02592Risdiplam0.004412%
BADD_D02604Ubrogepant0.000226%
BADD_D02616Calcium carbonate--
BADD_D02626Methoxyflurane--
BADD_D02629Niraparib--
The 10th Page    First    Pre   10    Total 10 Pages